Top and Current
Source: (remove) : Timothy Chiang
RSS • JSON • XML • CSV
Top and Current
Source: (remove) : Timothy Chiang
RSS • JSON • XML • CSV
Fri, March 15, 2024
[ Fri, Mar 15th 2024 ] - WOPRAI
Timothy Chiang Initiated (ANIP) at Buy on, Mar 15th, 2024
Thu, November 3, 2022
[ Thu, Nov 03rd 2022 ] - WOPRAI
Timothy Chiang Initiated (AKYA) at Buy and Held Target at $19 on, Nov 3rd, 2022
Mon, October 5, 2020
[ Mon, Oct 05th 2020 ] - WOPRAI
Timothy Chiang Upgraded (AMPH) to Buy on, Oct 5th, 2020

Timothy Chiang Initiated (ANIP) at Buy on, Mar 15th, 2024


Published on 2024-10-28 09:43:18 - WOPRAI, Timothy Chiang
  Print publication without navigation


Timothy Chiang of Capital One, Initiated "ANI Pharmaceuticals, Inc." (ANIP) at Buy on, Mar 15th, 2024.

Timothy has made no other calls on ANIP in the last 4 months.



There are 3 other peers that have a rating on ANIP. Out of the 3 peers that are also analyzing ANIP, 0 agree with Timothy's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Timothy

  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $77 on, Tuesday, March 5th, 2024
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $83 on, Monday, March 4th, 2024
  • Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Increased Target to $80 on, Friday, March 1st, 2024